MedTrace Logo

Pain Control for Laser Epilation in Pilonidal Disease

NCT06640946 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-06-18

No results posted yet for this study

Summary

It's unclear if the application of topical lidocaine prior to laser follicle ablation is effective in reducing discomfort from the procedure. This study will use a doubly blinded case-control model to evaluate pain scores after the procedure comparing topical lidocaine to placebo.

Conditions

  • Pilonidal Disease

Interventions

DRUG

Topical lidocaine

Topical lidocaine cream prior to laser follicle ablation

DRUG

Sham cream

Placebo cream without lidocaine will be placed and removed before laser.

Sponsors & Collaborators

  • David Mooney

    lead OTHER

Principal Investigators

  • Ashley P Stoeckel, MD · Boston Children's

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-05-01
Completion
2025-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06640946 on ClinicalTrials.gov